Venture capital firms Prolog Ventures and Holton Capital Group have provided funds to launch Sequoia Vaccines, a spin-out tackling urinary-tract infections from drug-discovery company Sequoia Sciences.
Venture capital firms Prolog Ventures and Holton Capital Group have provided funds to launch Sequoia Vaccines, a spin-out tackling urinary-tract infections from drug-discovery company Sequoia Sciences.
GCV provides the global corporate venturing community and their ecosystem partners with the information, insights and access needed to drive impactful open innovation. Across our three services - News & Analysis, Community & Events, and the GCV Institute - we create a network-rich environment for global innovation and capital to meet and thrive. At the heart of our community sits the GCV Leadership Society, providing privileged access to all our services and resources.
